One study identified AFAP1-AS1 as a potential biomarker for triple-negative breast cancer (TNBC), associated with cell proliferation and epithelial–mesenchymal transition (EMT) through specific histone modification patterns [57]. Here, AFAP1 is linked to triple-negative breast carcinoma.